Effect of comorbidities on outcomes and ivabradine effects in patients with chronic systolic heart failure in the SHIFT trial

被引：0
|
作者：
Bohm, Servier M. [1 ]
Borer, J. S. [2 ]
Ford, I. [3 ]
Lainscak, M. [4 ]
Komajda, M. [5 ]
Robertson, M. [3 ]
Tavazzi, L. [6 ]
Swedberg, K. [7 ]
机构：
[1] Univ Saarlandes Kliniken, Innere Med Klin 3, Homburg, Germany
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[4] Gen Hosp Celje, Dept Cardiol, Celje, Slovenia
[5] Univ Paris 06, La Pitie Salpetriere Hosp, Dept Cardiol, Paris, France
[6] Ettore Sansavini Hlth Sci Fdn, Maria Cecilia Hosp GVM Care & Res, Cotignola, Italy
[7] Univ Gothenbur, Sahlgrenska Acad, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1283
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [21] Ivabradine for systolic heart failure
    Meade, Courtney M.
    Clements, Jennifer N.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (03): : 52 - 54
  • [22] Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT
    Boehm, Michael
    Komajda, Michel
    Borer, Jeffrey S.
    Ford, Ian
    Maack, Christoph
    Tavazzi, Luigi
    Moyne, Aurelie
    Swedberg, Karl
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (02) : 373 - 381
  • [23] Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
    Boehm, Michael
    Borer, Jeffrey
    Ford, Ian
    Gonzalez-Juanatey, Jose R.
    Komajda, Michel
    Lopez-Sendon, Jose
    Reil, Jan-Christian
    Swedberg, Karl
    Tavazzi, Luigi
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (01) : 11 - 22
  • [24] Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
    Michael Böhm
    Jeffrey Borer
    Ian Ford
    Jose R. Gonzalez-Juanatey
    Michel Komajda
    Jose Lopez-Sendon
    Jan-Christian Reil
    Karl Swedberg
    Luigi Tavazzi
    Clinical Research in Cardiology, 2013, 102 : 11 - 22
  • [25] The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
    Voors, A. A.
    Van Veldhuisen, D. J.
    Robertson, M.
    Ford, I.
    Borer, J.
    Boehm, M.
    Komajda, M.
    Swedberg, K.
    Tavazzi, L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 162 - 163
  • [26] The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
    Voors, Adriaan A.
    van Veldhuisen, Dirk J.
    Robertson, Michele
    Ford, Ian
    Borer, Jeffrey S.
    Boehm, Michael
    Komajda, Michel
    Swedberg, Karl
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (04) : 426 - 434
  • [27] Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
    Koltowski, Lukasz
    KARDIOLOGIA POLSKA, 2010, 68 (11) : 1299 - 1302
  • [28] Ivabradine in Heart Failure: To SHIFT or Not to SHIFT
    Andres Schuster
    W. H. Wilson Tang
    Current Heart Failure Reports, 2011, 8 (1) : 1 - 3
  • [29] Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Dubost-Brama, Ariane
    Lerebours, Guy
    Tavazzi, Luigi
    LANCET, 2010, 376 (9744): : 875 - 885
  • [30] Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffey S.
    Ford, Ian
    Dubost-Brama, Ariane
    Lerebours, Guy
    Tavazzi, Luigi
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2010, 29 (7-8) : 1273 - 1273
12345